The lowest of the four biosafety levels and is suitable for work involving well-characterized agents not known to consistently cause disease in healthy adult humans. These organisms pose minimal ...

A former senior adviser to National Institute of Allergy and Infectious Diseases Director Dr. Anthony Fauci shared “confidential” communications with EcoHealth Alliance about how the agency was ...

On May 25, 2023, merely six weeks before the Wuhan Biosafety lab lost its NIH funding amid the controversy of possible lab leaks and connection with COVID-19, the U.S. proudly opened the doors of the ...

BSL-2 is designed for work with agents that pose moderate hazards to personnel and the environment. These agents are associated with human diseases that are generally treatable or preventable. Agents ...

Melanie Ott is director of the Gladstone Infectious Disease Institute in San Francisco, California, USA, and professor in the Department of Medicine, University of California, San Francisco, ...

The NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acids (NIH Guidelines) provide details regarding "the practices for constructing and handling: (i) recombinant nucleic acid ...

Guyana will soon benefit from its first ever Biosafety Level Three (BSL-3) laboratory which according to a Department of Public Information release yesterday, will offer patients improved diagnostic ...

When the COVID-19 pandemic arrived in the United States in 2020, the American research community experienced a sudden spike in funding. Universities, pharmaceutical companies, and state and federal ...

This policy is to formalize the University of Colorado Boulder’s obligation to ensure that research activities involving recombinant or synthetic nucleic acid molecules (rsNA) and bio hazardous ...

Update: Executive Order 14292, “Improving the Safety and Security of Biological Research”, issued on May 5, 2025, has ordered a suspension of all federally funded dangerous gain-of-function research ...